Target intelligence / Profile preview

Interferon-induced GTP-binding protein Mx2 (MX2)

Target
MX2
Molecular classification
Enzyme, Large dynamin-like GTPase, Interferon-stimulated gene product
01

Overview

Interferon-induced GTP-binding protein Mx2 (MX2) is a large dynamin-like GTPase induced by type I interferons (IFN-α/β), present in both nuclear and cytoplasmic forms, and primarily acts as a restriction factor against HIV-1 and some other viruses. MX2 binds the viral capsid after reverse transcription but before nuclear import and proviral integration, preventing successful infection by blocking nuclear trafficking of the viral genome, particularly in HIV-1; N-terminal domains and interactions with nuclear pore components are crucial for this activity. Its antiviral spectrum includes several herpesviruses (where GTPase function is required for activity) and possible inhibitory roles in hepatitis B virus. While MX2 is not itself a direct therapeutic target, it represents a key node in the innate immune response, and its upregulation by interferons underlies much of its biological significance.

Other names
MX dynamin-like GTPase 2MXBInterferon-regulated resistance GTP-binding protein MXBMyxovirus resistance protein 2p78-related proteinSecond interferon-induced protein p78interferon-induced GTP-binding protein Mx2interferon-regulated resistance GTP-binding protein MXB
02

Mechanism of action

Not directly targeted by drugs, but mechanism relates to enzyme-mediated hydrolysis of GTP and oligomerization to restrict viral nuclear import. The effect of interferon, an established therapeutic, is to induce MX2 expression.

03

Biological functions

Innate immune responseAntiviral defenseRegulation of nucleocytoplasmic transportCell cycle progression
04

Disease associations

Infection (notably HIV-1, herpesvirus, hepatitis B)Possible involvement in cancer (glioma; limited emerging evidence)Other
05

Safety considerations

No direct therapeutic use or targeting; thus, no established safety concerns. As an interferon-stimulated gene, overactivation or dysregulation could theoretically contribute to autoimmune or inflammatory pathology, but this is not characterized for MX2.
06

Interacting drugs

None reported in clinical use or advanced preclinical studies
07

Biomarkers

MX2 mRNA/protein can serve as a biomarker of interferon activity or host antiviral response, especially in studies of viral infections

Beyond the preview

Go deeper on Interferon-induced GTP-binding protein Mx2 (MX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interferon-induced GTP-binding protein Mx2 (MX2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call